verir2 warf1
Name
versr2
Label
Slow-Release Verapamil (SHHS2)
Description

Participant taking SLOW-RELEASE VERAPAMIL within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
arrythmia hypertension VERSR2
Slow-Release Verapamil (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total - 4,080 -
No - 3,565 -
Yes - 55 -
Unknown - 460 -
Slow-Release Verapamil (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 174 640 1,138 1,031 542 40 3,565
Yes 2 7 10 25 11 - 55
Unknown 8 60 173 144 71 4 460
Slow-Release Verapamil (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,636 1,929 3,565
Yes 25 30 55
Unknown 200 260 460
Slow-Release Verapamil (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,119 231 215 3,565
Yes 43 11 1 55
Unknown 425 14 21 460